Comparing TIMP-1 and Hsp70 in Blood and Saliva as Potential Prognostic Markers in HNSCC

(1) Background: Currently, there is no clinically used liquid biomarker in head and neck squamous cell carcinoma (HNSCC) patients. One reason could be the limited shedding of tumor material in early disease stages. Molecular diagnostics assessing both blood and especially saliva could potentially im...

Descripción completa

Detalles Bibliográficos
Autores principales: Rinecker, Jakob, Roesch, Romina, Krippgans, Sara, Nieberler, Markus, Stark, Leonhard, Stangl, Stefan, Haller, Bernhard, Fritsche, Kristin, Multhoff, Gabriele, Knopf, Andreas, Winter, Christof, Wollenberg, Barbara, Wirth, Markus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9775946/
https://www.ncbi.nlm.nih.gov/pubmed/36551979
http://dx.doi.org/10.3390/biomedicines10123225

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9775946/
https://www.ncbi.nlm.nih.gov/pubmed/36551979
http://dx.doi.org/10.3390/biomedicines10123225

Ejemplares similares